Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $3.21 billion. The enterprise value is $6.04 billion.
| Market Cap | 3.21B |
| Enterprise Value | 6.04B |
Important Dates
The next confirmed earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SGRY has 126.61 million shares outstanding. The number of shares has increased by 36.61% in one year.
| Shares Outstanding | 126.61M |
| Shares Change (YoY) | +36.61% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 107.69% |
| Float | 74.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.57 |
| PS Ratio | 1.17 |
| Forward PS | 1.05 |
| PB Ratio | 1.62 |
| P/FCF Ratio | 13.92 |
| PEG Ratio | 1.66 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.08, with an EV/FCF ratio of 26.18.
| EV / Earnings | n/a |
| EV / Sales | 2.20 |
| EV / EBITDA | 18.08 |
| EV / EBIT | 33.41 |
| EV / FCF | 26.18 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.52.
| Current Ratio | 1.71 |
| Quick Ratio | 1.32 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 9.05 |
| Debt / FCF | 13.10 |
| Interest Coverage | 0.94 |
Financial Efficiency
Return on equity (ROE) is -0.60%.
| Return on Equity (ROE) | -0.60% |
| Return on Assets (ROA) | -0.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $203,207 |
| Profits Per Employee | -$881 |
| Employee Count | 13,500 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 28.59 |
Taxes
| Income Tax | -300,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.58% in the last 52 weeks. The beta is 2.74, so SGRY's price volatility has been higher than the market average.
| Beta (1Y) | 2.74 |
| 52-Week Price Change | -39.58% |
| 50-Day Moving Average | 29.30 |
| 200-Day Moving Average | 31.46 |
| Relative Strength Index (RSI) | 29.76 |
| Average Volume (30 Days) | 915,337 |
Short Selling Information
The latest short interest is 8.27 million, so 6.54% of the outstanding shares have been sold short.
| Short Interest | 8.27M |
| Short Previous Month | 8.04M |
| Short % of Shares Out | 6.54% |
| Short % of Float | 11.13% |
| Short Ratio (days to cover) | 9.68 |
Income Statement
In the last 12 months, SGRY had revenue of $2.74 billion and -$11.90 million in losses. Loss per share was -$0.09.
| Revenue | 2.74B |
| Gross Profit | 647.50M |
| Operating Income | 329.30M |
| Pretax Income | -12.20M |
| Net Income | -11.90M |
| EBITDA | 334.10M |
| EBIT | 180.80M |
| Loss Per Share | -$0.09 |
Balance Sheet
The company has $195.90 million in cash and $3.02 billion in debt, giving a net cash position of -$2.83 billion or -$22.34 per share.
| Cash & Cash Equivalents | 195.90M |
| Total Debt | 3.02B |
| Net Cash | -2.83B |
| Net Cash Per Share | -$22.34 |
| Equity / Book Value | 1.99B |
| Book Value Per Share | 15.70 |
| Working Capital | 372.00M |
Cash Flow
In the last 12 months, operating cash flow was $293.80 million and capital expenditures -$63.00 million, giving a free cash flow of $230.80 million.
| Operating Cash Flow | 293.80M |
| Capital Expenditures | -63.00M |
| Free Cash Flow | 230.80M |
| FCF Per Share | $1.84 |
Margins
Gross margin is 23.60%, with operating and profit margins of 12.00% and -0.43%.
| Gross Margin | 23.60% |
| Operating Margin | 12.00% |
| Pretax Margin | -0.44% |
| Profit Margin | -0.43% |
| EBITDA Margin | 12.18% |
| EBIT Margin | 6.59% |
| FCF Margin | 8.41% |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.61% |
| Shareholder Yield | -36.61% |
| Earnings Yield | -0.37% |
| FCF Yield | 7.18% |
Analyst Forecast
The average price target for SGRY is $44.44, which is 76.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.44 |
| Price Target Difference | 76.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SGRY has an Altman Z-Score of 0.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.94 |
| Piotroski F-Score | 4 |